These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31611086)

  • 1. Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia.
    Kikuchi Y; Takahashi J; Hao K; Sato K; Sugisawa J; Tsuchiya S; Suda A; Shindo T; Ikeda S; Shiroto T; Matsumoto Y; Miyata S; Sakata Y; Shimokawa H
    Int J Cardiol; 2019 Dec; 297():8-13. PubMed ID: 31611086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.
    Mohri M; Shimokawa H; Hirakawa Y; Masumoto A; Takeshita A
    J Am Coll Cardiol; 2003 Jan; 41(1):15-9. PubMed ID: 12570938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery.
    Inokuchi K; Ito A; Fukumoto Y; Matoba T; Shiose A; Nishida T; Masuda M; Morita S; Shimokawa H
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):275-7. PubMed ID: 15475822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.
    Hang CL; Wang CP; Yip HK; Yang CH; Guo GB; Wu CJ; Chen SM
    Chest; 2005 Oct; 128(4):2593-8. PubMed ID: 16236929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients.
    Yang L; Mu L; Sun L; Qi F; Guo R
    Minerva Cardioangiol; 2017 Apr; 65(2):111-118. PubMed ID: 27249789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
    Masumoto A; Mohri M; Shimokawa H; Urakami L; Usui M; Takeshita A
    Circulation; 2002 Apr; 105(13):1545-7. PubMed ID: 11927519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study.
    Aksu T; Guler TE; Colak A; Baysal E; Durukan M; Sen T; Guray U
    BMC Cardiovasc Disord; 2015 Feb; 15():10. PubMed ID: 25885120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina.
    Otsuka T; Ibuki C; Suzuki T; Ishii K; Yoshida H; Kodani E; Kusama Y; Atarashi H; Kishida H; Takano T; Mizuno K
    Coron Artery Dis; 2008 Mar; 19(2):105-10. PubMed ID: 18300747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
    Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
    Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil Is an Effective Graft Vasodilator for Gastroepiploic Artery in Coronary Artery Bypass Grafting.
    Watanabe G; Yamaguchi S; Tomita S; Nishida Y
    Innovations (Phila); 2015; 10(4):268-72; discussion 272. PubMed ID: 26360979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of fasudil pretreatment combined with ischemia postconditioning on myocardial ischemia/reperfusion injury in rats.
    Li WN; Wu N; Shu WQ; Guan YE; Jia DL
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2748-58. PubMed ID: 25317813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
    Fukumoto Y; Mohri M; Inokuchi K; Ito A; Hirakawa Y; Masumoto A; Hirooka Y; Takeshita A; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):117-21. PubMed ID: 17414222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction.
    Shinozaki N; Ichinose H; Yahikozawa K; Shimada H; Hoshino K
    Int Heart J; 2007 Jul; 48(4):423-33. PubMed ID: 17827814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effects of Fasudil, a Rho-Kinase Inhibitor, After Spinal Cord Ischemia and Reperfusion in Rats.
    Ohbuchi M; Kimura T; Nishikawa T; Horiguchi T; Fukuda M; Masaki Y
    Anesth Analg; 2018 Mar; 126(3):815-823. PubMed ID: 29099428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention.
    Youssef AA; Wu CJ; Hang CL; Cheng CI; Yang CH; Chen CJ; Chen YH; Chai HT; Chua S; Yeh KH; Yip HK
    Circ J; 2006 Dec; 70(12):1538-42. PubMed ID: 17127795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 20. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.